These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16335874)

  • 1. Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus.
    Kawashita MY; Tsai K; Aoki V; Santi CG; Maruta CW; Rivitti E
    J Dermatol; 2005 Jul; 32(7):574-80. PubMed ID: 16335874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S; Platamone A; Alaimo R; Bongiorno MR
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
    Katz KH; Marks JG; Helm KF
    J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
    Doukaki S; Pistone G; Aricò M; Bongiorno MR
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
    Mimouni D; Anhalt GJ; Cummins DL; Kouba DJ; Thorne JE; Nousari HC
    Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
    Sarma N; Ghosh S
    Indian J Dermatol Venereol Leprol; 2007; 73(5):348-50. PubMed ID: 17921620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
    Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris.
    Baskan EB; Yilmaz M; Tunali S; Saricaoglu H
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1432-4. PubMed ID: 19470052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
    Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
    Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
    An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against desmoglein 1 in healthy subjects in endemic and nonendemic areas of pemphigus foliaceus (fogo selvagem) in Peru.
    Ortega Loayza AG; Ramos W; Elgart G; Bouman P; Jiménez G; Avila J; Rojas I; Vilcarromero M; Hurtado J; Lindo G; Galarza C
    Int J Dermatol; 2006 May; 45(5):538-42. PubMed ID: 16700787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of pemphigus].
    van Beek N; Zillikens D; Schmidt E
    Hautarzt; 2019 Apr; 70(4):243-253. PubMed ID: 30887081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on fogo selvagem, an endemic form of pemphigus foliaceus.
    Aoki V; Rivitti EA; Diaz LA;
    J Dermatol; 2015 Jan; 42(1):18-26. PubMed ID: 25558948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigus foliaceus in an adolescent.
    Adah A; Hill K; Wyatt J; Didion L
    J Pediatr; 2014 Nov; 165(5):1062.e1. PubMed ID: 25151193
    [No Abstract]   [Full Text] [Related]  

  • 19. Brazilian pemphigus foliaceus, endemic pemphigus foliaceus, or fogo selvagem (wild fire).
    Sampaio SA; Rivitti EA; Aoki V; Diaz LA
    Dermatol Clin; 1994 Oct; 12(4):765-76. PubMed ID: 7805306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.